Frontlight ResearchEarly access
Endometrial cancer trials in United States
199 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDiscovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
- Where
- New York
- Age
- 18 years and over
- People
- 1,120
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT06096688 - No phaseNot yet taking people in United StatesDevelopment Of An Endometrial Cancer Educational Tool
- Where
- Houston
- Age
- 18 years and over
- People
- 250
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07739745 - Phase 2Not yet taking people in United StatesEvaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 66
- Run by
- University of Oklahoma
See details and how to joinNCT07737795 - No phaseTaking peopleThe DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
- Where
- Birmingham
- Age
- 18 years to 99 years
- People
- 1,700
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT03538665 - Phase 3Taking peoplePuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Where
- Albuquerque, Ann Arbor, Austin, Baltimore, Bethlehem, Brooklyn, Camden, Chicago, Cincinnati, Cleveland, Columbus, Dayton, Detroit, Eugene, Fairfax, Falls Church, Fort Wayne, Greenville, Hershey, Hilliard, Honolulu, Houston, Indianapolis, Jupiter, Kennewick, Knoxville, La Jolla, Lancaster, Los Angeles, Miami, Miami Beach, Minneapolis, Morgantown, Nashville, New Port Richey, Norfolk, Orange, Orlando, Paramus, Peoria, Philadelphia, Pinehurst, Pittsburgh, Portland, Richmond, Roanoke, Scarborough, Seattle, Silver Spring, Sioux Falls, Stony Brook, Sylvania, Tampa, The Bronx, Tucson, Tyler, Urbana, Washington D.C., Waukesha, West Palm Beach, White Plains, Willow Grove, York
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07044336 · EU 2024-518777-34-00 - Phase 1Taking peopleStudy of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Dallas, Detroit, Houston, Phoenix, Portland, Raleigh, San Diego, St Louis, Tampa
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06974110 - No phaseNot yet taking people in United StatesWeb-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial
- Where
- Columbus
- Age
- 40 years to 69 years
- People
- 90
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07723235 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Birmingham, Cleveland, Dallas, Detroit, Fairfax, Farmington Hills, Fort Worth, Houston, Iowa City, Irvine, Orange, Richardson, Sacramento, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleTrial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
- Where
- Miami, New Haven
- Age
- 18 years and over
- People
- 200
- Run by
- Yale University
See details and how to joinNCT05761561 - Phase 2Taking peopleAbemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
- Where
- Los Angeles
- People
- 32
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT04469764 - Phase 1Taking peoplePhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- Where
- Houston
- Age
- 18 years and over
- People
- 43
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092373 - No phaseTaking peopleCervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
- Where
- Minneota
- Age
- 18 years and over
- People
- 40
- Run by
- University of Minnesota
See details and how to joinNCT07075731 - Phase 2Taking peopleA Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 75
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07209449 - No phaseTaking peopleThe Better, Harder, Faster, Stronger Study
- Where
- Winston-Salem
- Age
- 55 years and over
- People
- 35
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07220512 - No phaseTaking peopleFasting InTervention for Endometrial Cancer
- Where
- Miami
- Age
- 18 years and over
- People
- 42
- Run by
- University of Miami
See details and how to joinNCT07622901 - No phaseEnrolling by invitationAdvancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
- Where
- New Brunswick
- Age
- 18 years and over
- People
- 266
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT06834204 - No phaseTaking peopleAcceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
- Where
- Rochester
- Age
- 45 years and over
- People
- 25
- Run by
- Mayo Clinic
See details and how to joinNCT07527143 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Atlanta, Aurora, Boston, Cleveland, Columbus, Dallas, Detroit, Fairfax, Germantown, Grand Rapids, Houston, Iowa City, Kansas City, Lake Mary, Los Angeles, Nashville, New Haven, New Orleans, New York, Portland, San Antonio, San Francisco, St Louis, Tampa, West Valley City
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - No phaseTaking peopleNavigation Intervention for Adolescent and Young Adult Cancer Survivors
- Where
- Pasadena
- Age
- 21 years to 45 years
- People
- 25
- Run by
- Kaiser Permanente
See details and how to joinNCT07406087 - No phaseTaking peopleAdaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
- Where
- New Brunswick
- Age
- 18 years to 90 years
- People
- 30
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07643012 - Phase 2Taking peopleProgestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
- Where
- Albuquerque, Charlottesville, Iowa City, Salt Lake City
- Age
- 18 years and over
- People
- 140
- Run by
- New Mexico Cancer Research Alliance
See details and how to joinNCT07436793 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - Phase 1/2Taking peopleA Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Where
- Atlanta, Boston, Chicago, Dallas, Detroit, Fairfax, Houston, Jacksonville, Las Vegas, Nashville, New York, Oklahoma City, Orange, Phoenix, Rochester, Salt Lake City, San Francisco, Santa Monica, Sarasota, Seattle, Sioux Falls, Spokane, Tampa
- Age
- 18 years and over
- People
- 360
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT05377996 - Phase 1Taking peoplePhase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 31
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07318324 - No phaseTaking peoplePredicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Where
- Forth Worth, Fort Smith, Frederick, Oklahoma City, Springfield, St Louis, Temple
- Age
- 18 years and over
- People
- 2,000
- Run by
- Elephas
See details and how to joinNCT07327489